Travis Halliburton v. HHS - Influenza, Guillain Barre Syndrome (GBS) (2025)
Case summary [AI summaries can sometimes make mistakes]
Travis Halliburton filed a petition on October 10, 2023, alleging that he developed Guillain-Barre syndrome after receiving an influenza vaccine on October 14, 2020. He sought compensation under the Vaccine Table and alleged that the effects of the illness lasted for more than six months.
Respondent filed a Rule 4(c) report on June 16, 2025, conceding that Mr. Halliburton suffered Guillain-Barre syndrome as a Table injury and that the legal requirements for compensation were satisfied.
Chief Special Master Corcoran granted entitlement on June 18, 2025. The public entitlement and damages decisions do not describe Mr.
Halliburton's treatment course in detail. They establish the vaccine, the Guillain-Barre diagnosis, respondent's concession of entitlement, and the parties' agreed damages resolution.
On November 26, 2025, Chief Special Master Corcoran awarded Mr. Halliburton $200,000.00 for pain and suffering, payable as a lump sum through counsel's IOLTA account.
A later fee decision concerned attorney fees and costs only and was not additional vaccine-injury compensation. Mr.
Halliburton was represented by David John Carney of Green & Schafle LLC in Philadelphia, Pennsylvania.
Theory of causation
Influenza vaccine on October 14, 2020 causing Guillain-Barre syndrome. ENTITLEMENT CONCEDED; COMPENSATED. Respondent conceded Table GBS in a June 16, 2025 Rule 4(c) report; entitlement granted June 18, 2025. Public decisions contain limited treatment narrative. Petition filed October 10, 2023; damages decision by Chief SM Brian H. Corcoran on November 26, 2025. Award $200,000 pain and suffering, lump sum through counsel IOLTA. Later March 16, 2026 fee award was attorney compensation only. Attorney: David John Carney, Green & Schafle LLC, Philadelphia PA.
Source PDFs
USCOURTS-cofc-1_23-vv-01777